These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22356480)

  • 61. Systematic RHD genotyping in Brazilians reveals a high frequency of partial D in transfused patients serologically typed as weak D.
    Miranda MR; Dos Santos TD; Castilho L
    Transfus Apher Sci; 2021 Dec; 60(6):103235. PubMed ID: 34389204
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of molecular typing and serological methods in solving discrepant results of weak and partial D (Rh) in South Egypt.
    Bakry RM; Nasreldin E; Hassaballa AE; Mansour SM; Aboalia SA
    Asian J Transfus Sci; 2019; 13(2):110-114. PubMed ID: 31896917
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo- or autoantibodies?
    Pham BN; Roussel M; Peyrard T; Beolet M; Jan-Lasserre V; Gien D; Ripaux M; Bourgouin S; Kappler-Gratias S; Rouger P; Le Pennec PY
    Transfusion; 2011 Dec; 51(12):2679-85. PubMed ID: 21658048
    [TBL] [Abstract][Full Text] [Related]  

  • 65. RhD variants in Caucasians: consequences for checking clinically relevant alleles.
    Ansart-Pirenne H; Asso-Bonnet M; Le Pennec PY; Roussel M; Patereau C; Noizat-Pirenne F
    Transfusion; 2004 Sep; 44(9):1282-6. PubMed ID: 15318849
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Partial D phenotypes and genotypes in the Chinese population.
    Ye L; Wang P; Gao H; Zhang J; Wang C; Li Q; Han S; Guo Z; Yang Y; Zhu Z
    Transfusion; 2012 Feb; 52(2):241-6. PubMed ID: 21790636
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Weak D types 38 and 11: determination of frequencies in a Brazilian population and validation of an easy molecular assay for detection.
    Dezan MR; Oliveira VB; Conrado M; Luz F; Gallucci A; Oliveira TGM; Sabino EC; Rocha V; Mendrone A; Dinardo CL
    Immunohematology; 2020 Jun; 36(2):47-53. PubMed ID: 32667816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular biology of partial D and weak D: implications for blood bank practice.
    Flegel WA; Wagner FF
    Clin Lab; 2002; 48(1-2):53-9. PubMed ID: 11833677
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RHD DNA screening for weak D, DEL and D+/- 'chimeras'.
    Gassner C; Rozman P
    Vox Sang; 2006 Aug; 91(2):184. PubMed ID: 16907882
    [No Abstract]   [Full Text] [Related]  

  • 70. High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype.
    Dezan MR; Oliveira VB; Gomes ÇN; Luz F; Gallucci AJ; Bonifácio SL; Alencar CS; Sabino EC; Pereira AC; Krieger JE; Rocha V; Mendrone-Junior A; Dinardo CL
    J Clin Lab Anal; 2018 Nov; 32(9):e22596. PubMed ID: 29943480
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients.
    Clarke G; Hannon J; Berardi P; Barr G; Cote J; Fallis R; Alport T; Lane D; Petraszko T; Ochoa G; Goldman M
    Transfusion; 2016 Dec; 56(12):2980-2985. PubMed ID: 27611891
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identifying D-positive donors using a second automated testing platform.
    Goldman M; Resz I; Cote J; Ochoa G; Angus N
    Immunohematology; 2013; 29(3):97-100. PubMed ID: 24325169
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential of commercial anti-D reagents in the identification of partial D variants in Indian population.
    Kulkarni SS; Vasantha K; Gupte SC; Mohanty D; Ghosh K
    Indian J Med Res; 2007 May; 125(5):641-4. PubMed ID: 17642499
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen.
    Souza Silva TC; Cruz BR; Costa SS; Chiba AK; Barros MMO; Langhi DM; Bordin JO
    Blood Transfus; 2020 Jul; 18(4):295-303. PubMed ID: 32697929
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Weak D type 42 cases found in individuals of European descent.
    St-Louis M; Richard M; Côté M; Ethier C; Long A
    Immunohematology; 2011; 27(1):20-4. PubMed ID: 22356482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. On the complexity of D antigen typing: a handy decision tree in the age of molecular blood group diagnostics.
    Flegel WA; Denomme GA; Yazer MH
    J Obstet Gynaecol Can; 2007 Sep; 29(9):746-52. PubMed ID: 17825140
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 78. Nation-wide investigation of RHD variants in Thai blood donors: Impact for molecular diagnostics.
    Thongbut J; Laengsri V; Raud L; Promwong C; I-Na-Ayudhya C; Férec C; Nuchnoi P; Fichou Y
    Transfusion; 2021 Mar; 61(3):931-938. PubMed ID: 33377204
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular basis of D variants in Chinese persons.
    Yan L; Wu J; Zhu F; Hong X; Xu X
    Transfusion; 2007 Mar; 47(3):471-7. PubMed ID: 17319828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76.
    Gassner C; Utz I; Schennach H; Ramoni A; Steiner H; Scholz S; Kreklau U; Körmöczi GF
    Transfusion; 2013 Nov; 53(11 Suppl 2):2954-9. PubMed ID: 23550956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.